Prevalence of polycythemia vera and essential thrombocythemia

American Journal of Hematology

Volumn 83, Issue 5, 2008, Pages 359-362

  Ma, Xiaomei ^a,d   Vanasse, Gary ^b   Cartmel, Brenda ^a   Wang, Yun ^a   Selinger, H Andrew ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Prohealth Physicians Inc   (United States)

^d Box 208034 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE SPECIFIC CARE; AGED; ALGORITHM; ARTICLE; FEMALE; HEALTH INSURANCE; HEALTH SERVICE; HUMAN; INFANT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; POLYCYTHEMIA VERA; POPULATION RESEARCH; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOCYTHEMIA; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; AREA UNDER CURVE; CHILD; CHILD, PRESCHOOL; CONNECTICUT; FEMALE; HUMANS; INFANT; INSURANCE CARRIERS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MEDICAID; MEDICARE; MIDDLE AGED; POLYCYTHEMIA VERA; PREVALENCE; THROMBOCYTHEMIA, HEMORRHAGIC; UNITED STATES;

EID: 42949130540     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21129     Document Type: Article

References (8)

1. Fritz A, editor. International Classification of Diseases for Oncology, 3rd ed. World Health Organization; 2000.
2. Census. Available at http://factfinder.census.gov/servlet/DTTable?_bm= y&-geo_id=04000US09&-ds_name=PEP_2006_EST&-mt_name= PEP_2006_EST_G2006_T001 (accessed July 2007).
3. Population Division, US Census Bureau. Annual estimates of the population by five-year age groups for the United States: April 1, 2000 to July 1, 2005, NC-EST2005-01; 2006.
4. NHLBI, NCI, State of the Science implementation working group meeting for myeloproliferative, myelodysplastic, and marrow failure syndromes, 2003.
5. Berglund S, Zettervall O. Incidence of polycythemia vera in a defined population. Eur J Haematol 1992;48:20-26.
6. Johansson P. Epidemiology of the myeloproliferative disorders polycythemia vera and essential thrombocythemia. Semin Thromb Hemost 2006;32:171-173.
7. Ruggeri M, Tosetto A, Frezzato M, Rodeghiero F. The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosis. Ann Intern Med 2003;139:470-475.
8. CMS. Available at http://www.cms.hhs.gov/IdentifiableDataFiles/ 02_StandardAnalyticalFiles.asp#TopOfPage (accessed July 2007).